-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
National Health Investors Analyst Ratings
National Health Investors Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 7.54% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 5.8% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -11.54% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 17.94% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 24.88% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 23.15% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 33.55% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | -4.6% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 9.27% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 11.01% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 14.47% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | -4.6% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -30.62% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 5.8% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -25.42% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -11.54% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 42.23% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 64.77% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
08/08/2018 | 38.76% | Cantor Fitzgerald | $75 → $80 | Maintains | Neutral |
05/31/2018 | 30.08% | Wells Fargo | $68 → $75 | Maintains | Market Perform |
04/17/2018 | 4.07% | Keybanc | $70 → $60 | Maintains | Underweight |
12/19/2017 | — | Keybanc | Downgrades | Sector Weight → Underweight | |
10/23/2017 | — | Capital One | Initiates Coverage On | → Equal-Weight | |
10/11/2017 | 38.76% | SunTrust Robinson Humphrey | → $80 | Initiates Coverage On | → Hold |
National Health Investors Questions & Answers
The latest price target for National Health Investors (NYSE: NHI) was reported by Truist Securities on September 26, 2022. The analyst firm set a price target for $61.00 expecting NHI to rise to within 12 months (a possible 5.80% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Truist Securities, and National Health Investors maintained their hold rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on September 26, 2022 so you should expect the next rating to be made available sometime around September 26, 2023.
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $64.00 to $61.00. The current price National Health Investors (NHI) is trading at is $57.66, which is out of the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist Securities | $64 → $61 | Maintains | Hold |
06/21/2022 | 7.54% | BMO Capital | → $62 | Downgrades | Outperform → Market Perform |
04/19/2022 | 5.8% | BMO Capital | $63 → $61 | Maintains | Outperform |
02/01/2022 | -11.54% | Credit Suisse | → $51 | Initiates Coverage On | → Underperform |
01/07/2022 | 17.94% | BMO Capital | → $68 | Upgrades | Market Perform → Outperform |
07/23/2021 | 24.88% | Wells Fargo | $74 → $72 | Maintains | Equal-Weight |
06/18/2021 | 23.15% | BMO Capital | → $71 | Upgrades | Underperform → Market Perform |
03/30/2021 | 33.55% | Capital One | → $77 | Downgrades | Overweight → Equal-Weight |
01/13/2021 | -4.6% | Mizuho | → $55 | Downgrades | Neutral → Underperform |
01/08/2021 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
12/14/2020 | — | Keybanc | Upgrades | Underweight → Sector Weight | |
09/02/2020 | 9.27% | Stifel | → $63 | Reinstates | → Hold |
06/24/2020 | 11.01% | SunTrust Robinson Humphrey | $61 → $64 | Maintains | Hold |
06/17/2020 | 14.47% | Wells Fargo | $54 → $66 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/22/2020 | -4.6% | Mizuho | $60 → $55 | Downgrades | Buy → Neutral |
05/14/2020 | -30.62% | Keybanc | $43 → $40 | Maintains | Underweight |
04/23/2020 | 5.8% | SunTrust Robinson Humphrey | $77 → $61 | Maintains | Hold |
04/21/2020 | -25.42% | Keybanc | $65 → $43 | Maintains | Underweight |
03/26/2020 | -11.54% | Wells Fargo | $82 → $51 | Maintains | Equal-Weight |
02/05/2020 | — | Berenberg | Initiates Coverage On | → Buy | |
01/07/2020 | 42.23% | BMO Capital | → $82 | Upgrades | Underperform → Market Perform |
12/20/2019 | 64.77% | Mizuho | → $95 | Assumes | → Buy |
02/20/2019 | — | BMO Capital | Downgrades | Market Perform → Underperform | |
08/08/2018 | 38.76% | Cantor Fitzgerald | $75 → $80 | Maintains | Neutral |
05/31/2018 | 30.08% | Wells Fargo | $68 → $75 | Maintains | Market Perform |
04/17/2018 | 4.07% | Keybanc | $70 → $60 | Maintains | Underweight |
12/19/2017 | — | Keybanc | Downgrades | Sector Weight → Underweight | |
10/23/2017 | — | Capital One | Initiates Coverage On | → Equal-Weight | |
10/11/2017 | 38.76% | SunTrust Robinson Humphrey | → $80 | Initiates Coverage On | → Hold |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
09/26/2022 | 5.8% | Truist 證券 | 64 美元 → 61 美元 | 維護 | 保持 |
2022 年 6 月 21 日 | 7.54% | BMO Capital | → 62 美元 | 降級 | 跑贏大盤 → 市場表現 |
04/19/2022 | 5.8% | BMO Capital | 63 美元 → 61 美元 | 維護 | 跑贏大盤 |
2022 年 1 月 2 日 | -11.54% | 瑞士信貸 | → 51 美元 | 啓動覆蓋範圍開啓 | → 表現不佳 |
2022 年 7 月 1 日 | 17.94% | BMO Capital | → 68 美元 | 升級 | 市場表現 → 跑贏大盤 |
2021 年 7 月 23 日 | 24.88% | 富國銀行 | 74 美元 → 72 美元 | 維護 | 重量相等 |
06/18/2021 | 23.15% | BMO Capital | → 71 美元 | 升級 | 表現不佳 → 市場表現 |
03/30/2021 | 33.55% | 資本一號 | → 77 美元 | 降級 | 超重 → 重量相等 |
2021 年 1 月 13 日 | -4.6% | 瑞穗市 | → 55 美元 | 降級 | 中性 → 跑贏大盤 |
01/08/2021 | — | BMO Capital | 降級 | 市場表現 → 表現不佳 | |
2020 年 12 月 14 日 | — | Keybanc | 升級 | 減持 → 行業權重 | |
2020 年 2 月 9 日 | 9.27% | Stifel | → 63 美元 | 恢復 | → 按住 |
06/24/2020 | 11.01% | SunTrust 羅賓遜·漢弗萊 | 61 美元 → 64 美元 | 維護 | 保持 |
2020 年 6 月 17 日 | 14.47% | 富國銀行 | 54 美元 → 66 美元 | 維護 | 重量相等 |
06/08/2020 | — | JMP 證券 | 恢復 | → 市場表現 | |
05/22/2020 | -4.6% | 瑞穗市 | 60 美元 → 55 美元 | 降級 | 買入 → 中性 |
05/14/2020 | -30.62% | Keybanc | 43 美元 → 40 美元 | 維護 | 體重不足 |
04/23/2020 | 5.8% | SunTrust 羅賓遜·漢弗萊 | 77 美元 → 61 美元 | 維護 | 保持 |
2020 年 4 月 21 日 | -25.42% | Keybanc | 65 美元 → 43 美元 | 維護 | 體重不足 |
2020 年 3 月 26 日 | -11.54% | 富國銀行 | 82 美元 → 51 美元 | 維護 | 重量相等 |
02/05/2020 | — | 貝倫貝格 | 啓動覆蓋範圍開啓 | → 購買 | |
01/07/2020 | 42.23% | BMO Capital | → 82 美元 | 升級 | 表現不佳 → 市場表現 |
12/20/2019 | 64.77% | 瑞穗市 | → 95 美元 | 假設 | → 購買 |
02/20/2019 | — | BMO Capital | 降級 | 市場表現 → 表現不佳 | |
2018 年 8 月 8 日 | 38.76% | 坎託·菲茨傑拉德 | 75 美元 → 80 美元 | 維護 | 中立 |
05/31/2018 | 30.08% | 富國銀行 | 68 美元 → 75 美元 | 維護 | 市場表現 |
2018 年 4 月 17 日 | 4.07% | Keybanc | 70 美元 → 60 美元 | 維護 | 體重不足 |
12/19/2017 | — | Keybanc | 降級 | 板塊權重 → 減持 | |
10/23/2017 | — | 資本一號 | 啓動覆蓋範圍開啓 | → 重量相等 | |
10/11/2017 | 38.76% | SunTrust 羅賓遜·漢弗萊 | → 80 美元 | 啓動覆蓋範圍開啓 | → 按住 |
National Health Investors Questions & Answers
全國健康投資者問題與解答
The latest price target for National Health Investors (NYSE: NHI) was reported by Truist Securities on September 26, 2022. The analyst firm set a price target for $61.00 expecting NHI to rise to within 12 months (a possible 5.80% upside). 5 analyst firms have reported ratings in the last year.
Truist Securities於2022年9月26日公佈了國家健康投資者(紐約證券交易所代碼:NHI)的最新目標股價。該分析公司將目標股價定爲61.00美元,預計NHI將在12個月內升至12個月內(可能上漲5.80%)。去年有5家分析公司公佈了評級。
The latest analyst rating for National Health Investors (NYSE: NHI) was provided by Truist Securities, and National Health Investors maintained their hold rating.
Truist Securities提供了National Health Investors(紐約證券交易所代碼:NHI)的最新分析師評級,國民健康投資者維持其持有評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Health Investors, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Health Investors was filed on September 26, 2022 so you should expect the next rating to be made available sometime around September 26, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與National Health Investors的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。國家健康投資者的最新評級是在2022年9月26日公佈的,因此您應該預計下一個評級將在2023年9月26日左右公佈。
While ratings are subjective and will change, the latest National Health Investors (NHI) rating was a maintained with a price target of $64.00 to $61.00. The current price National Health Investors (NHI) is trading at is $57.66, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但最新的國家健康投資者(NHI)評級維持不變,目標股價爲64.00美元至61.00美元。國家健康投資者(NHI)目前的交易價格爲57.66美元,超出了分析師的預期區間。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧